Innovative Pediatric Solutions NovaSight specializes in AI-driven eye-tracking systems for diagnosing and treating childhood vision impairments, presenting a unique opportunity to target pediatric clinics, ophthalmologists, and telemedicine providers seeking advanced, home-based therapeutic options.

Growing Market Adoption With recent FDA clearance and awards confirming product efficacy, NovaSight is well-positioned to expand its reach within the U.S. and international markets, offering a compelling opportunity to partner with hospitals and vision care networks looking to upgrade standard screening and therapy practices.

Home Therapy Expansion The company's development of CureSight for home use opens sales channels toward parents, specialized pediatric care providers, and insurance payers interested in effective, at-home treatment alternatives that increase compliance and reduce the long-term costs of vision impairment.

Strategic Investment Growth Having secured $8 million in Series A funding from strategic investors and received industry recognitions, NovaSight demonstrates strong growth potential, making it an attractive partner for investors and distributors aiming to capitalize on the expanding digital health and pediatric vision market.

Technology Differentiation NovaSight’s proprietary combination of eye-tracking and AI technologies offers a competitive edge in accurate, real-time assessment and personalized treatment, creating opportunities to collaborate with device manufacturers and healthcare providers seeking innovative, data-enabled diagnostic and therapeutic tools.